Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Survey reveals why rheumatism patients struggle with Follow-Up care

NCT ID NCT05613712

Knowledge-focused Sponsor: University Hospital, Grenoble Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study surveyed 229 people with chronic inflammatory rheumatism (like rheumatoid arthritis) and their doctors to find out what makes it hard to follow care recommendations after a hospital visit. The goal was to identify barriers to good outpatient management. No treatment was tested; instead, the study gathered information to potentially improve future care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help improve how doctors manage chronic inflammatory rheumatism outside the hospital, leading to better long-term care.
What could go wrong
This is a completed survey study, not a treatment trial. It identifies problems but does not test any solution, so direct patient benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

229 people

The number who actually took part.

Started

Feb 2023

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The SCORIC population targeted by the patient questionnaire represents all patients followed by the rheumatology department of the CHU Grenoble Alpes, having benefited from a holistic analysis of their disease and their comorbidities. The referring physician population will be generated from the medical records of the patients of the SCORIC cohort.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient cohort : * men and women over 18 years of age * Informed volunteers who have consented to participate in the study * have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis * have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department * Cohort of referring physicians : * volunteers who received informed information and consented to participate in the study * be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes Exclusion Criteria: * Patient cohort : * psychiatric pathologies or history of behavioural disorders * persons referred to in articles L1121-5 to L1121-8 of the Public Health Code * persons under guardianship or curatorship * not affiliated to the social security system * minors * Refusal to participate by the patient and/or unreturned questionnaire * Cohort of referring physicians: * the physician is no longer the patient's referring physician * refusal of the doctor to participate and/or questionnaire not returned

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic inflammatory disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis inflammatory disease Patient Compliance psoriatic arthritis rheumatoid arthritis Spondylarthritis Spondylarthropathies spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic inflammatory disease

Contacts and locations

Locations

  • CHU Grenoble Alpes

    Grenoble, 38043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.